Mike Hennessy Jr, President and CEO

As HIV has become a manageable chronic condition, and even curable in some cases, the role of pharmacists cannot be understated.

With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.

The need for additional data on safety and efficacy of medicines both new and old that assess all potential risk factors is ever present, with health system pharmacists at the front lines.

Pharmacy schools have also been seeing a change not only in education about personalized patient care and community-centered care.

Artificial intelligence has helped ensure a data-driven methodology for evaluating eligibility criteria for clinical trials, facilitating more inclusive trial design.

October offers us a chance to take a step back to admire the hard work and dedication that pharmacists show day in and day out.

With back-to-school season already over and the fall rapidly approaching, health systems are bracing for another season of influenza, COVID-19, and respiratory syncytial virus.

As we approach November 27, 2024, new regulations and updates may arise for health system pharmacies to be aware of to remain compliant.

Although the price and availability timeline of norgestrel have yet to be determined, experts already agree that it is an important step toward increased access to contraception.

Renewed focus on the potential this drug can provide patients is upon us as we continue to strive for greater and better care and treatment for patients throughout US health systems.

The American Society of Clinical Oncology (ASCO) Annual Meeting includes updates from some of the most important clinical trials being conducted in the field of oncology.

The DEA’s decision allows some health care providers to have more leeway in prescribing certain controlled substances.

Key topics in May include mental illness for pharmacists, pharmacy technicians, and PharmD candidates.

Issues highlighted in May include mental illness as well as asthma and allergies.

A strong theme of recent conferences was the push for greater awareness of pharmacists' roles in patient advocacy and patient education.

On March 1, 2023, Eli Lilly and Company said it would take steps to cap insulin prices, and Novo Nordisk and Sanofi followed suit 2 weeks later.

With the rapid increase in the number of pharmacy schools, there has been a struggle to fill all open spots within each school.

Pharmacy Times® commits to incorporating DEI concepts into our coverage and focusing on social determinants of health (SDOH).

Pharmacy Times® commits to incorporating DEI concepts into our coverage and focusing on social determinants of health (SDOH).

Change is upon us, and opportunities for advancing treatment opportunities for patients continue to look strong.

There's no better time to remind pharmacists that they are vital in the fight against CVD.

Some US pharmacies are experiencing medication shortages as a result of COVID-19, influenza, and respiratory syncytial virus cases.

In this special January issue covering ASH and SABCS, we have divided the publication by conference.

Cases of COVID-19, influenza, and respiratory syncytial virus are creating a so-called tripledemic.

An analysis found an estimated 1.3 million US adults with diabetes rationed their insulin in the past year by delaying prescription refills, skipping doses, or using smaller doses.

Looking to 2023, there remain significant opportunities on the road ahead to improve patient outcomes and patient-centered oncology treatment and care.

From improving access to offering precision care, students are at the forefront of innovation.